-+ 0.00%
-+ 0.00%
-+ 0.00%

What Investors Got Wrong About Marvell Technology Before A 79% Jump

Simply Wall St·11/05/2026 17:31:13
Listen to the news

If you only skimmed headlines about Nvidia, Google and record AI data center spending, Marvell Technology might have looked like a side character rather than the one delivering the punch. For Marvell Technology shareholders, the return from the start of the year was 79.1%, including dividends. If you were weighing those bullish December 2025 forecasts against warnings about heavy data center dependence back on 2026-01-01, which evidence would have deserved more of your trust?

Narratives are how investors here put a case on the record, with explicit assumptions about revenue, margins and the multiple. Those assumptions imply an estimated Fair Value.

Marvell Technology is not the only name tied to this theme. Zero in on 53 AI infrastructure stocks and compare how each one is priced.

The Two Marvell Technology Stories Investors Had To Weigh

The shares cost US$84.98 at the start of the period, and anyone looking at Marvell Technology had to choose which story felt more believable.

The bullish narrative put Fair Value at US$133. It argued that custom silicon, optical interconnects and advanced networking could lift revenue, with profit margins assumed to change from a loss of 1.4% to 85.0% by 2028.

The bearish view set Fair Value at US$64.31. It stressed that 74% of turnover coming from data centers increased exposure if hyperscaler spending or cloud demand slowed, with margins only reaching 19.6% in its assumptions.

NasdaqGS:MRVL Trailing 12-Month Earnings & Revenue History as at Nov 2026
NasdaqGS:MRVL Trailing 12-Month Earnings & Revenue History as at Nov 2026

What The Results Changed For The Marvell Technology Thesis

The clearest new fact was Marvell Technology reporting Q2 2027 revenue of US$2,739.3 million and net income of US$308 million, with net margin at 11.2% versus 9.7% a year earlier. That outcome leaned toward the bullish story of improving profitability but still sat far from its extreme margin assumptions, so the period cut both ways rather than settling the argument.

The whole debate turned on how quickly profitability could scale in an AI heavy business mix. For any similar stock, you would test that claim directly against net income and margin in each results release, not just against top line growth headlines.

What Marvell Technology’s Run Now Asks You To Believe

Marvell Technology trades at US$160 after a 79.1% gain from the start of the year. The selected Narrative’s Fair Value sits below that price, so its author sees today’s quote as already baking in a lot of good news.

The pitch leans on Marvell’s role in high speed optical links and custom AI chips. For today’s valuation to hold, a buyer would need to assume that hyperscaler AI infrastructure buildouts keep supporting that full stack position at the scale described.

"The core thesis for Marvell in 2026 to 2028 rests on a single structural insight: as AI clusters scale from a single rack to hundreds of XPUs operating as one coherent system, the value of the silicon that connects and controls those chips is converging with, and in some cases exceeding, the value of the chips themselves. Marvell has positioned itself at precisely this inflection point, offering custom silicon design, 1.6T optical DSPs, silicon photonics fabric, and CXL memory switching in one integrated portfolio."

The price and this Narrative do not agree. → Uncover what this Narrative says Marvell Technology is actually worth

How Could You Get There Earlier?

What if your next investment idea came before the headlines? Go straight to the companies whose prices and our estimates still disagree. Three places to start, with the names waiting behind the link.

  • Company 1 - 25% below our estimate - builds an AI enabled productivity layer on top of established enterprise software systems.
  • Company 2 - 38% below our estimate - advances late stage therapies targeting cystic fibrosis and other serious chronic conditions.
  • Company 3 - 37% below our estimate - rolls out AI based tools and stricter carrier vetting to curb fraud and claims costs.

Those are three of them. See all 35 potentially undervalued companies →